A Critical Next Step in Advancing Phio’s PH-762 Program to Treat Cutaneous Carcinomas Phio Pharmaceuticals Corp.
VANCOUVER, BC / ACCESS Newswire / March 19, 2026 / Prince Silver Corp. (CSE:PRNC)(OTCQB:PRNCF)(T130:Frankfurt) ("Prince ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results